[1]胡志良.糖化血红蛋白水平对2型糖尿病伴急性心肌梗死患者经皮冠状动脉介入术预后及支架内再狭窄程度的影响[J].新乡医学院学报,2019,36(12):1159-1162.[doi:10.7683/xxyxyxb.2019.12.014]
　HU Zhi-liang.Effects of glycosylated hemoglobin level on the prognosis of patients with type 2 diabetes mellitus with acute myocardial infarction after percutaneous coronary intervention and the degree of stent restenosis[J].Journal of Xinxiang Medical University,2019,36(12):1159-1162.[doi:10.7683/xxyxyxb.2019.12.014]
点击复制

糖化血红蛋白水平对2型糖尿病伴急性心肌梗死患者经皮冠状动脉介入术预后及支架内再狭窄程度的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年12
页码:
1159-1162
栏目:
临床研究
出版日期:
2019-12-12

文章信息/Info

Title:
Effects of glycosylated hemoglobin level on the prognosis of patients with type 2 diabetes mellitus with acute myocardial infarction after percutaneous coronary intervention and the degree of stent restenosis
作者:
胡志良
（驻马店市中心医院心血管内三科，河南　驻马店　463000）
Author(s):
HU Zhi-liang
（Department of NO.3 Cardiology，the Central Hospital of Zhumadian，Zhumadian 463000，Henan Province，China）
关键词:
糖化血红蛋白; 2型糖尿病; 急性心肌梗死; 经皮冠状动脉介入术; 支架内再狭窄
Keywords:
glycosylated hemoglobin;  type 2 diabetes;  acute myocardial infarction;  percutaneous coronary intervention;  stent restenosis
分类号:
R587.1
DOI:
10.7683/xxyxyxb.2019.12.014
文献标志码:
A
摘要:
目的　探讨糖化血红蛋白（HbA1c）水平对2型糖尿病伴急性心肌梗死患者经皮冠状动脉介入术预后及支架内再狭窄程度的影响。方法　选择2015年3月至2018年3月于驻马店市中心医院行冠状动脉介入术治疗的2型糖尿病合并急性心肌梗死患者162例为研究对象。根据术后6个月HbA1c水平分为A组（HbA1c≤5.6%）（n=38）、B组（5.6%< HbA1c<6.5%）（n=71）和C组（n=53）（HbA1c≥6.5%）。比较术后6个月3组患者空腹血糖、血脂水平、肾小球滤过率、心血管不良事件发生率及支架内再狭窄发生率。结果　术后6个月，3组患者总胆固醇、三酰甘油、低密度脂蛋白、高密度脂蛋白水平及肾小球滤过率两两比较差异无统计学意义（P>0.05）；3组患者空腹血糖水平两两比较差异均有统计学意义（P<0.05）。术后6个月，A组、B组、C组患者心血管不良事件发生率分别为23.7%（9/38）、5.6%（4/71）、26.4%（14/53），支架内再狭窄发生率分别为34.1%（13/38）、11.3%（8/71）、28.3%（15/53）；A组和C组患者心血管不良事件发生率和支架内再狭窄发生率显著高于B组（χ2=6.062、10.560、8.381、5.832，P<0.05），A组与C组患者心血管不良事件发生率和支架内再狭窄发生率比较差异无统计学意义（χ2=0.091、0.362，P>0.05）。结论　5.6%< HbA1c<6.5%时2型糖尿病伴急性心肌梗死患者经皮冠状动脉介入术后的预后效果显著优于HbA1c≤5.6%及HbA1c≥6.5%，且术后6个月支架再狭窄率低，狭窄程度轻。
Abstract:
Objective　To investigate the effect of glycosylated hemoglobin(HbA1c) on the prognosis of percutaneous coronary intervention and stent restenosis in patients with type 2 diabetes mellitus with acute myocardial infarction.Methods　
A total of 162 patients with type 2 diabetes complicated with acute myocardial infarction who underwent coronary intervention in the Central Hospital of Zhumadian City from March 2015 to March 2018 were selected as subjects.The patients were divided into group A (HbA1c≤5.6%)（n=38），group B (5.6%< HbA1c<6.5%) （n=71）and group C (HbA1c≥6.5%)（n=53） according to the level of HbA1c at six months after surgery.The fasting blood glucose，lipid level，glomerular filtration rate，incidence of adverse cardiovascular events and incidence of stent restenosis in the three groups were compared at six months after surgery.Results　At six months after the operation，there was no significant difference in total cholesterol，triglyceride，low density lipoprotein，high density lipoprotein and glomerular filtration rate among the three groups (P>0.05).There was statistic different in the fasting glucose level of patients among the three groups (P<0.05).At six months after the operation，the incidence of adverse cardiovascular events in the group A，group B and group C was 23.7% (9/38)，5.6% (4/71) and 26.4% (14/53)，respectively，and the incidence of stent restenosis was 34.1% (13/38)，11.3% (8/71) and 28.3% (15/53)，respectively.The incidence of cardiovascular adverse events and the incidence of stent restenosis in the group A and group C was significantly higher than that in the group B (χ2=6.062，10.560，8.381，5.832; P<0.05)，while there was no significant difference in the incidence of cardiovascular adverse events and the incidence of stent restenosis between the group A and group C (χ2=0.091，0.362；P>0.05).Conclusion　When 5.6%< HbA1c<6.5%，the prognosis of patients with type 2 diabetes with acute myocardial infarction after percutaneous coronary intervention is significantly better than that of the patients with HbA1c≤5.6% and HbA1c≥6.5%，and the stent restenosis rate is lower and the stenosis degree is milder at six months after surgery.

参考文献/References:

［1］　DAI G H，GAO W L，BI D X，et al.Efficacy of traditional Chinese medicine in patients with acute myocardial infarction suffering from diabetes mellitus［J］.J Tradit Chin Med，2018，38(3):412-418.
［2］　PLEVA L，KUKLA P，HLINOMAZ O.Treatment of coronary in-stent restenosis: a systematic review［J］.J Geriatr Cardiol，2018，15(2):173-184.
［3］　DAVIES M J，D′ALESSIO D A，FRADKIN J，et al.Management of hyperglycemia in type 2 diabetes，2018.A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) ［J］.Diabetes Care，2018，41(12):2669-2701.
［4］　何亚菲，林文华，卢宇杰，等.单核细胞/高密度脂蛋白胆固醇比值与急性ST段抬高型心肌梗死患者血栓负荷的关系［J］.中国循环杂志，2018，32(1):46-49.
［5］　ZHAO D F，EDELMAN J J，SECO M,et al.Long-term outcomes following off-pump coronary artery bypass grafting: fixed-effects versus random-effects models［J］.J Am Coll Cardiol，2018，72(3):345-347.
［6］　WANG J L，QIN Z，WANG Z J，et al.New predictors of instent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent［J］.J Geriatr Cardiol，2018，15(2):137-145.
［7］　BRAVATA D M，DAGGY J，BROSCH J，et al.Comparison of risk factor control in the year after discharge for ischemic stroke versus acute myocardial infarction［J］.Stroke，2018，49(2):296-303.
［8］　AGGARWAL B，SHAH G K，RANDHAWA M，et al.Utility of glycated hemoglobin for assessment of glucose metabolism in patients with ST-segment elevation myocardial infarction［J］.Am J Cardiol，2016，117(5):749-753.
［9］　ZHAO S，MURUGIAH K，LI N,et al.Admission glucose and in-hospital mortality after acute myocardial infarction in patients with or without diabetes: a cross-sectional study［J］.Chin Med J (Engl)，2017，130(7):767-775.
［10］　ZULLO A R，HERSEY M，LEE Y，et al.Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction［J］.Diabetes Obes Metab，2018，20(12):2724-2732.
［11］　ZACCARDI F，WEBB D R，DAVIES M J，et al.Risk factors and outcome differences in hypoglycaemia-related hospital admissions: a case-control study in England［J］.Diabetes Obes Metab，2017，19(10):1371-1378.
［12］　HELLER S R，BERGENSTAL R M，WHITE W B，et al.Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the examine trial［J］.Diabetes Obes Metab，2017，19(5):664-671.

相似文献/References:

[1]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[2]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[3]朱明慧.免疫抑制比浊法测定糖化血红蛋白Alc[J].新乡医学院学报,2002,19(01):047.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[6]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[7]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[8]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[9]蒋铁桥,张群,杨刚毅,等.短期胰岛素泵强化治疗对初诊2型糖尿病患者β细胞功能的影响[J].新乡医学院学报,2010,27(04):000.
[10]王润之,黄艳群.LPIN1基因的研究进展[J].新乡医学院学报,2010,27(04):413.
[11]王小瑞,郑献召,韩凯,等.沙格列汀对2型糖尿病伴缺血性脑卒中患者血糖水平及认知功能的影响[J].新乡医学院学报,2022,39(12):1163.[doi:10.7683/xxyxyxb.2022.12.012]
　WANG Xiaorui,ZHENG Xianzhao,HAN Kai,et al.Effect of saxagliptin on blood glucose level and cognitive function of patients with type 2 diabetes and ischemic stroke[J].Journal of Xinxiang Medical University,2022,39(12):1163.[doi:10.7683/xxyxyxb.2022.12.012]

更新日期/Last Update: 2019-12-05